402 results on '"Day, Nicholas P. J."'
Search Results
2. Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics study
3. Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral Hospital
4. Global and Regional Seroprevalence, Incidence, Mortality of, and Risk Factors for Scrub Typhus: A Systematic Review and Meta-Analysis
5. Implementing the WHO AWaRe antibiotic book guidance in lower-resource settings: the case of the Lao PDR
6. Understanding reticence to occupy free, novel-design homes: A qualitative study in Mtwara, Southeast Tanzania
7. Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
8. Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis
9. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
10. Ethics and Antimalarial Drug Resistance
11. Clinical antiviral efficacy of remdesivir in COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
12. IL-1R2-based biomarker models predict melioidosis mortality independent of clinical data
13. Diversity of Human Enterovirus Co-Circulations in Five Kindergartens in Bangkok between July 2019 and January 2020
14. Geographical distribution of scrub typhus and risk of Orientia tsutsugamushi infection in Indonesia: Evidence mapping
15. Molecular diagnosis and genotyping of Orientia tsutsugamushi in Maesot and Chiangrai, Thailand
16. Correction: A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model
17. Urinary catecholamine excretion, cardiovascular variability, and outcomes in tetanus
18. Cost, health impacts and cost effectiveness of iceless refrigeration in India's last-mile vaccine cold chain delivery
19. Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
20. The prognostic and diagnostic value of intraleukocytic malaria pigment in patients with severe falciparum malaria
21. Modelling the cost‐effectiveness of pulse oximetry in primary care management of acute respiratory infection in rural northern Thailand
22. A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model
23. Improving the diagnosis of severe malaria in African children using platelet counts and plasma Pf HRP2 concentrations
24. Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies
25. Correction: Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial
26. Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial
27. Excess Mortality Attributable to Hospital-Acquired Antimicrobial-Resistant Infections: A 2-Year Prospective Surveillance Study in Northeast Thailand
28. Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry
29. Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
30. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital
31. Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers
32. Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
33. Assessment In Vitro of the Antimalarial and Transmission-Blocking Activities of Cipargamin and Ganaplacide in Artemisinin-Resistant Plasmodium falciparum
34. Community engagement for malaria elimination in the Greater Mekong Sub-region: a qualitative study among malaria researchers and policymakers
35. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
36. Have we really failed to roll back malaria?
37. Serosurvey of Scrub Typhus in Indonesia: A Cross-Sectional Analysis of Archived Fever Studies Samples
38. Trends in Hospital Antimicrobial Use in the Lao PDR Using Regular Point-Prevalence Surveys-Evidence to Evaluate and Improve Treatment Guideline Use
39. Age-Dosed Single Low Dose Primaquine in Falciparum-Infected African Children with G6pd Deficiency is Well Tolerated and Safe
40. Global antibiotic consumption and usage in humans, 2000–18: a spatial modelling study
41. Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion
42. Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis
43. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial
44. Orientia tsutsugamushi dynamics in vectors and hosts: ecology and risk factors for foci of scrub typhus transmission in northern Thailand
45. Systematic review of the scrub typhus treatment landscape: Assessing the feasibility of an individual participant-level data (IPD) platform
46. Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
47. Comparative clinical characteristics and outcomes of patients with community acquired bacteremia caused by Escherichia coli, Burkholderia pseudomallei and Staphylococcus aureus: A prospective observational study (Ubon-sepsis)
48. Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
49. Bactericidal activities and post-antibiotic effects of ofloxacin and ceftriaxone against drug-resistant Salmonella enterica serovar Typhi
50. Effectiveness of a multifaceted prevention programme for melioidosis in diabetics (PREMEL): A stepped-wedge cluster-randomised controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.